PE/VC Fundraising - Acquisitions & Exits - Funding Rounds - Tell us about your Deals - Sign up for Newsletter

Woodford Investment Management

Clinical-Stage Biopharmaceutical Company Autolus Secures US$80M Series C Funding

UK-based Cell Medica Raise £60M Series C Financing

Oxford Nanopore Technologies Raises £100M in Funding

IP Group’s portfolio company Oxford Sciences Innovation announces £230m fundraising

European oncology company Carrick Therapeutics nets $95m from ARCH, Woodford and other investors

UK-based developer of battery materials technology, Naxeon, scores £30M from Woodford and existing investors

IP Group’s portfolio company, Ultrahaptics, nets £10.1M funding round, led by Woodford Investment Management

AMO Pharma nets $25M in financing round from Woodford Investment Management

Mereo BioPharma, a biopharmaceutical company, raises $119M

Immunocore, a biotechnology company, secures $320M (£205M) in private financing round